- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 15, 2025 | 12.65M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $6.51M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $6.62M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $1.38M |
| Short Term Investments | Q1 2025 · Mar 31, 2024 | $3.02M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $9.65M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $5.3M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $38.42M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $38.03M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $13.29M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $11.86M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $19.92M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $18.6M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $36.08M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $34.58M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $61.69M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $59.97M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 12.45M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $478.12K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$604.82K |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.04 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.04 |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $126.65K |
| Net Income | Q1 2025 · Mar 31, 2024 | $457.23K |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $765.83K |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $2.82M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $6.4M |
| Revenue | Q1 2025 · Mar 31, 2024 | $9.22M |